{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:15:41Z","timestamp":1777032941203,"version":"3.51.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Delirium is a frequent complication in hospitalized patients, particularly in older adults, and is associated with significant morbidity and mortality. Acetylcholinesterase inhibitors (AChEIs) have been proposed as potential agents to reduce occurrence and severity of delirium. This study aimed to evaluate the efficacy of AChEIs for both prophylaxis and treatment of delirium in hospitalized patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>We searched PubMed, Embase, and Web of Science. The study was registered on PROSPERO (CRD42024563798).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION:<\/jats:title>\n            <jats:p>Studies comparing AChEIs and placebo for delirium in hospitalized patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION:<\/jats:title>\n            <jats:p>The main outcome of interest was delirium occurrence, while secondary outcomes included duration, severity, and hospital length of stay (LOS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS:<\/jats:title>\n            <jats:p>Subgroup analyses were performed based on prophylaxis or treatment of delirium. Statistical analysis was performed in RStudio 4.4.0 with a random effects model, and heterogeneity was assessed with <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>. Risk of Bias 2 was used for bias assessment. We screened 1306 records and included ten studies: eight studies focusing on prophylaxis after surgery and two on treatment of established delirium. A total of 731 patients were analyzed: 365 in the AChEIs group and 366 in the placebo group. AChEIs significantly reduced delirium occurrence (risk ratio = 0.68 [0.47\u20130.98]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.039). No significant effects were observed for delirium duration (mean difference [MD] = \u20130.16 d [\u20130.9 to 0.62 d]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.23), delirium severity (standardized mean difference [SMD] = \u20130.08 [\u20130.58 to 0.41]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.74), or LOS (MD = \u20130.82 d [\u20132.03 to 0.40 d]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.19). Subgroup analysis showed a tendency for better outcomes when AChEIs were used as prophylaxis, with a significant reduction in delirium duration in this subgroup (SMD= \u20130.32 [\u20130.56 to \u20130.07]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01). No significant differences in adverse events were identified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>AChEIs are effective in reducing occurrence of delirium when used prophylactically in patients undergoing elective surgery. AChEIs did not significantly impact on delirium duration, severity, or hospital LOS. Further studies are needed to explore the potential benefits or harms of AChEIs in different patient populations and settings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006786","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:00:54Z","timestamp":1754323254000},"page":"e2054-e2061","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Acetylcholinesterase Inhibitors for Delirium Prevention: A Systematic Review and Meta-Analysis"],"prefix":"10.1097","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5268-4668","authenticated-orcid":false,"given":"Leonardo Zumerkorn","family":"Pipek","sequence":"first","affiliation":[{"name":"Department of Neurology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina, University of Sao Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna Salema","family":"Pascual","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Bologna, Bologna, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela Farias Vidigal","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina, University of Sao Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina, University of Sao Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz H.","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina, University of Sao Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"R1-20251007","doi-asserted-by":"crossref","first-page":"e5970","DOI":"10.1002\/gps.5970","article-title":"The impact of rivastigmine on post-surgical delirium and cognitive impairment; a randomized clinical trial.","volume":"38","author":"Massoudi","year":"2023","journal-title":"Int J Geriatr Psychiatry"},{"key":"R2-20251007","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41572-020-00223-4","article-title":"Delirium.","volume":"6","author":"Wilson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20251007","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jalz.2016.03.005","article-title":"The short-term and long-term relationship between delirium and cognitive trajectory in older surgical patients.","volume":"12","author":"Inouye","year":"2016","journal-title":"Alzheimers Dement"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jama.2010.1013","article-title":"Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: A meta-analysis.","volume":"304","author":"Witlox","year":"2010","journal-title":"JAMA"},{"key":"R5-20251007","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/0269216312457214","article-title":"Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: A systematic review.","volume":"27","author":"Hosie","year":"2013","journal-title":"Palliat Med"},{"key":"R6-20251007","doi-asserted-by":"crossref","first-page":"h2538","DOI":"10.1136\/bmj.h2538","article-title":"Outcome of delirium in critically ill patients: Systematic review and meta-analysis.","volume":"350","author":"Salluh","year":"2015","journal-title":"BMJ"},{"key":"R7-20251007","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/alz.12807","article-title":"Donepezil treatment is associated with improved outcomes in critically ill dementia patients via a reduction in delirium.","volume":"19","author":"Lieberman","year":"2023","journal-title":"Alzheimers Dement"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/geriatrics8010024","article-title":"Preoperative risk factors associated with increased incidence of postoperative delirium: Systematic review of qualified clinical studies.","volume":"8","author":"Karageorgos","year":"2023","journal-title":"Geriatrics (Basel)"},{"key":"R9-20251007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000542-200601000-00005","article-title":"Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients.","volume":"104","author":"Pandharipande","year":"2006","journal-title":"Anesthesiology"},{"key":"R10-20251007","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/gerona\/63.7.764","article-title":"Cholinergic deficiency hypothesis in delirium: A synthesis of current evidence.","volume":"63","author":"Hshieh","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.56.3.408","article-title":"Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.","volume":"56","author":"Shinotoh","year":"2001","journal-title":"Neurology"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00259-016-3349-x","article-title":"Cholinergic imaging in dementia spectrum disorders.","volume":"43","author":"Roy","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(10)61855-7","article-title":"Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: A multicentre, double-blind, placebo-controlled randomised trial.","volume":"376","author":"van Eijk","year":"2010","journal-title":"Lancet"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"104171","DOI":"10.1016\/j.archger.2020.104171","article-title":"Pharmacologic interventions for prevention of delirium in hospitalized older people: A meta-analysis.","volume":"90","author":"Le\u00f3n-Salas","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"key":"R15-20251007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s42077-020-00087-6","article-title":"Rivastigmine patch (Exelon patch) compared to melatonin patch in prevention of postoperative delirium in the elderly.","volume":"12","author":"Hussien","year":"2020","journal-title":"Ain-Shams J Anaesthesiol"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/gps.4569","article-title":"Rivastigmine patch reduces the incidence of postoperative delirium in older patients with cognitive impairment.","volume":"32","author":"Youn","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"R17-20251007","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/gps.2801","article-title":"Rivastigmine in the treatment of postoperative delirium: A pilot clinical trial.","volume":"27","author":"Zaslavsky","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1111\/j.1532-5415.2011.03691.x","article-title":"Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture.","volume":"59","author":"Marcantonio","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1017\/S1041610209991359","article-title":"Rivastigmine in the treatment of delirium in older people: A pilot study.","volume":"22","author":"Overshott","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"R20-20251007","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/CCM.0b013e31819da780","article-title":"Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery\u2014a randomized controlled trial.","volume":"37","author":"Gamberini","year":"2009","journal-title":"Crit Care Med"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/gps.1679","article-title":"A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement.","volume":"22","author":"Sampson","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00019442-200512000-00010","article-title":"Donepezil in the prevention and treatment of post-surgical delirium.","volume":"13","author":"Liptzin","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"R23-20251007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s13054-022-04260-1","article-title":"Association between cholinesterase activity and critical illness brain dysfunction.","volume":"26","author":"Hughes","year":"2022","journal-title":"Crit Care"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5958\/2321-1024.2019.00011.4","article-title":"A retrospective study on use of neostigmine for management of non mechanical bowel obstruction.","volume":"7","author":"Kumar","year":"2019","journal-title":"Int J Contemp Surg"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:19:41Z","timestamp":1759846781000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006786","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]}}}